Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer

NCT07424560 · clinicaltrials.gov ↗

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Bladder Cancer Recurrence
Adjuvant Therapy for Bladder Cancer
Progression of Bladder Cancer

Interventions

GENETIC: Multiplex Mutation Detection System for Bladder Cancer (Nucleic Acid Mass Spectrometry)

Sponsor

Zhilong Dong